Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 15;114(4):529-539.
doi: 10.1093/cvr/cvy023.

Vascular smooth muscle contraction in hypertension

Affiliations
Review

Vascular smooth muscle contraction in hypertension

Rhian M Touyz et al. Cardiovasc Res. .

Abstract

Hypertension is a major risk factor for many common chronic diseases, such as heart failure, myocardial infarction, stroke, vascular dementia, and chronic kidney disease. Pathophysiological mechanisms contributing to the development of hypertension include increased vascular resistance, determined in large part by reduced vascular diameter due to increased vascular contraction and arterial remodelling. These processes are regulated by complex-interacting systems such as the renin-angiotensin-aldosterone system, sympathetic nervous system, immune activation, and oxidative stress, which influence vascular smooth muscle function. Vascular smooth muscle cells are highly plastic and in pathological conditions undergo phenotypic changes from a contractile to a proliferative state. Vascular smooth muscle contraction is triggered by an increase in intracellular free calcium concentration ([Ca2+]i), promoting actin-myosin cross-bridge formation. Growing evidence indicates that contraction is also regulated by calcium-independent mechanisms involving RhoA-Rho kinase, protein Kinase C and mitogen-activated protein kinase signalling, reactive oxygen species, and reorganization of the actin cytoskeleton. Activation of immune/inflammatory pathways and non-coding RNAs are also emerging as important regulators of vascular function. Vascular smooth muscle cell [Ca2+]i not only determines the contractile state but also influences activity of many calcium-dependent transcription factors and proteins thereby impacting the cellular phenotype and function. Perturbations in vascular smooth muscle cell signalling and altered function influence vascular reactivity and tone, important determinants of vascular resistance and blood pressure. Here, we discuss mechanisms regulating vascular reactivity and contraction in physiological and pathophysiological conditions and highlight some new advances in the field, focusing specifically on hypertension.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Calcium-dependent regulation of vascular smooth muscle cell (VSMC) contraction. Vasoconstrictors induce VSMC contraction by increasing the intracellular levels of Ca2+. Vasoactive peptides, such as Ang II, bind to G protein-coupled receptors (GPCRs) activating PLC leading to (i) production of IP3 and (ii) formation of DAG. IP3 binds to the IP receptor Ca2+ channel (InsP3R) and induces Ca2+ release from the sarcoplasmic reticulum (SR). DAG causes activation of PKC, which influences Ca2+ channels, such as store-operated Ca2+ channel (SOC), second messenger-operated Ca2+ channel (SMOC), receptor-operated Ca2+ channel (ROC), voltage-gated Ca2+ channel (VOC), and the Na+–Ca2+ exchanger (NCX). PKC also stimulates activity of the ryanodine Ca2+ channel (RyR) inducing release of Ca2+ from the SR. MLCP activity is reduced by CPI-17 phosphorylation. Ca2+ binds to calmodulin and activates the MLCK, leading to MLC20 phosphorylation at Ser19, actin polymerization, and vascular contraction.
Figure 2
Figure 2
ROCK-induced contraction of VSMCs. Vasoactive agents bind to their respective GPCRs leading to release of RhoA from a guanine nucleotide dissociation inhibitor (GDI). RhoA translocates to the membrane. Mechanisms involving RhoA activation also involve transactivation of receptor tyrosine kinases (RTKs). GEFs promote exchange of Guanosine diphosphate (GDP) to Guanosine triphosphate (GTP), activating the RhoA-ROCK pathway. Activated ROCK renders MLCP inactive by phosphorylation of CPI-17 and/or zipper-interacting protein (ZIPK), facilitating MLC20 phosphorylation and vascular contraction. Increased Ca2+ may directly activate ROCK through phosphatidylinositol-4, 5-bisphosphate 3-kinase (PI3K)-dependent pathways.
Figure 3
Figure 3
VSMC contraction and oxidative stress. Nox-derived ROS influence cellular Ca2+ homeostasis and pro-contractile signalling. Calcium also influences Nox-derived ROS generation, through Nox5, a Ca2+-sensitive Nox isoform that produces O2. Nox4 activation leads to production of H2O2. High levels of ROS, cause oxidative modifications of Ca2+ channels, ryanodine receptors (RyR), actin, actin-binding proteins as well as TRP cation channel, subfamily M, Member 2 (TRPM2). TRPM2, a redox-sensitive Ca2+ channel indirectly activated by H2O2 through poly (ADP-ribose) polymerase (PARP) activation in the nucleus and consequent Adenosine diphosphate-ribose (ADPR) production. Once released to the cytosol, ADPR binds and activates TRPM2, stimulating Ca2+ influx. Dashed line indicates that reduced MLCP activity results in icreased MLC20 activation.

References

    1. Savoia C, Burger D, Nishigaki N, Montezano A, Touyz RM.. Angiotensin II and the vascular phenotype in hypertension. Expert Rev Mol Med 2011; 13:11–20. - PubMed
    1. Intengan HD, Schiffrin EL.. Structure and mechanical properties of resistance arteries in hypertension role of adhesion molecules and extracellular matrix determinants. Hypertension 2000; 36:312–318. - PubMed
    1. Montezano AC, Tsiropoulou S, Dulak-Lis M, Harvey A, Camargo LDL, Touyz RM.. Redox signaling, Nox5 and vascular remodeling in hypertension. Curr Opin Nephrol Hypertens 2015; 24:425–433. - PMC - PubMed
    1. Touyz RM, Schiffrin EL.. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000; 52:639–672. - PubMed
    1. Endemann DH, Schiffrin EL.. Endothelial dysfunction. J Am Soc Nephrol 2004; 15:1983–1992. - PubMed

Publication types

MeSH terms